Cover Image
Market Research Report
Product code 
1022924

Autoimmune Disease Diagnostics: Global Markets

Published: | BCC Research | 223 Pages | Delivery time: 1-2 business days

Price

Back to Top
Autoimmune Disease Diagnostics: Global Markets
Published: August 6, 2021
BCC Research
Content info: 223 Pages
Delivery time: 1-2 business days
  • ALL
  • Description
  • Table of Contents
Description

Highlights:

The global market for autoimmune disease diagnostics should grow from $13.7 billion in 2021 to $17.0 billion by 2026 with a compound annual growth rate (CAGR) of 4.4% for the period of 2021-2026.

Autoimmune disease diagnostics market for rheumatoid arthritis should grow from $4.1 billion in 2021 to $5.1 billion by 2026 with a compound annual growth rate (CAGR) of 4.9% for the period of 2021-2026.

Autoimmune disease diagnostics market for systemic lupus erythematosus should grow from $2.6 billion in 2021 to $3.3 billion by 2026 with a compound annual growth rate (CAGR) of 4.8% for the period of 2021-2026.

Report Scope:

The report will provide details about autoimmune disease diagnostics used in the treatment of autoimmune disease and how the market has been influenced by the pandemic of COVID-19. This report will also highlight the current and future market potential of autoimmune disease diagnostics with detailed analyses of the competitive environments between companies. Drivers, restraints, opportunities, pricing analysis, prevalence or incidence autoimmune disease and regulatory scenarios will also be covered. The report includes a market projection for 2026 and market shares for key players.

The report segments the market for autoimmune disease diagnostics based on technology, gender, indications and geography. Based on technology, the market is segmented into indirect immunofluorescence (IIF), enzyme-linked immunosorbent assay (ELISA), ImmunoBlot, multiplex immunoassays and others. Based on indications, the market is segmented into type 1 diabetes, rheumatoid arthritis (RA), psoriasis/psoriatic arthritis, multiple sclerosis, inflammatory bowel disease, systemic lupus erythematosus (SLE), and others (pernicious anemia, celiac disease, autoimmune vasculitis, myasthenia gravis, Hashimoto's thyroiditis, Sjogren's syndrome, Graves' disease, Addison's disease, etc.). Based on gender, the market is segmented into male and female.

By geography, the market has been segmented into North America, Europe, the Asia-Pacific and the Rest of the World. A detailed analysis of major countries such as the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico, the Gulf Cooperation Council countries and South Africa will be covered in the regional segments. For market estimates, data will be provided for 2020 as the base year, with estimates for 2021 and forecast values for 2026.

Report Includes:

  • 37 data tables and 33 additional tables
  • An overview of the global market for autoimmune disease diagnostics
  • Estimation of the market size and analyses of the global market trends, with data from 2019, 2020 estimates for 2021 with projection of CAGR through 2026
  • Market share analysis of autoimmune disease diagnostics based on technology, indication, region and gender and identification of new opportunities, challenges, and technological changes within the industry
  • Detailed description of autoimmune disorder & therapies, and causes such as intrinsic factors, environmental factors, and lifestyle factors, and insights into new diagnostic pathway for autoimmune and inflammatory disorders
  • Discussion on role of bioinformatics and biomarkers on autoimmune disorder therapies and information on standardization of test results
  • Coverage of new product launches in the therapeutics for autoimmune diseases and performance methods in the detection of autoimmune antibodies
  • Detailed analysis of the current market trends, market forecast, and discussion of technological, and regulatory elements that are affecting the future marketplace
  • Comprehensive company profiles of major players in the industry, including Biomerieux, Thermo Fisher Scientific, Siemens Healthcare Diagnostics, Beckman Coulter, Becton Dickinson and Abbott
Table of Contents
Product Code: PHM160B

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • What's New in This Report?
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 Summary and Highlights

  • Report Highlights

Chapter 3 Market and Technology Background

  • Autoimmune Disorders and Therapies
  • Causes of Autoimmune Diseases
  • Intrinsic Factors
  • Environmental Factors
  • Lifestyle Factors
  • Key Challenges in the Industry
  • Standardization of Test Results
  • Lack of Awareness Among Patients of Autoimmune Complications
  • Shortage of Skilled Technicians for Performing Diagnostic Assays
  • Emerging Technologies in Autoimmune Diagnostics
  • Bioinformatics
  • Biomarkers
  • Applications for Mobile Phones
  • Lab Automation

Chapter 4 Market Dynamics

  • Market Drivers
  • Increasing Epidemiology of Autoimmune Diseases
  • Rise in the Geriatric Population
  • Rising Awareness of Autoimmune Diseases
  • New Diagnostic Pathway for Autoimmune and Inflammatory Disorders
  • Market Restraints
  • Low Availability of Diagnosis Kits in Laboratories
  • High Cost of Autoimmune Disease Diagnostics
  • Market Opportunities
  • Launch of New Therapeutics for Autoimmune Diseases
  • Growing Rate of Autoimmunity in Population

Chapter 5 Market Breakdown by Gender

  • Global Market for Autoimmune Disease Diagnostics
  • Females
  • Market Size and Forecast
  • Market Analysis
  • Males
  • Market Size and Forecast
  • Market Analysis

Chapter 6 Market Breakdown by Technology

  • Global Market for Autoimmune Disease Diagnostics by Technology
  • Indirect Immunofluorescence (IIF)
  • Indications
  • Methodology
  • Test Results
  • Advantages and Limitations of the IIF-ANA Test
  • Market Size and Forecast
  • Market Analysis
  • Enzyme-linked Immunosorbent Assay (ELISA)
  • Indication
  • Methodology
  • Advantages and Limitations of the ELISA Assay for ANA
  • Market Size and Forecast
  • Market Analysis
  • ImmunoBlot
  • Western Blot
  • Dot Blot
  • Line Blot
  • Market Size and Forecast
  • Market Analysis
  • Multiplex Immunoassays
  • Flow Cytometry
  • Microarray
  • Market Size and Forecast
  • Market Analysis
  • Other Technology
  • Agglutination
  • Double Immune Diffusion (DID)
  • Counter Immuno Electrophoresis (CIEP)
  • Market Size and Forecast
  • Market Analysis
  • Prevalence of ANA in Various Connective Tissue Diseases (CTD)
  • Summary of Performance Methods in the Detection of Autoimmune Antibodies
  • Autoimmune Products Sold by Companies

Chapter 7 Market Breakdown by Indication

  • Global Market for Autoimmune Disease Diagnostics by Indication
  • Type 1 Diabetes
  • Rheumatoid Arthritis (RA)
  • Psoriasis/Psoriatic Arthritis
  • Multiple Sclerosis
  • Inflammatory Bowel Disease
  • Systemic Lupus Erythematosus
  • Other Autoimmune Diseases

Chapter 8 Market Breakdown by Region

  • Global Market for Autoimmune Disease Diagnostics by Region
  • North America
  • Europe
  • Asia-Pacific
  • Rest of World

Chapter 9 Impact of COVID-19 on Autoimmune Disease Diagnostics Market

  • Autoimmune Disease and COVID-19 Treatment
  • Complexities of Diagnosis and Management of COVID-19 in Autoimmune Diseases

Chapter 10 Value Chain Analysis

  • Demand Chain Analysis
  • Customers (Patients)
  • Payers
  • Supply Chain Analysis
  • Laboratories
  • Manufacturers

Chapter 11 Regulatory Scenario

  • European Regulations
  • North American Regulations
  • U.S. Regulations
  • Canadian Regulations
  • Latin American Regulations
  • Asia-Pacific Regulations
  • Future Regulatory Trends

Chapter 12 Competitive Landscape

  • Global Company Share Analysis
  • Mergers and Acquisitions
  • Agreements, Launches, Collaborations and Partnerships
  • Business SWOT Analysis

Chapter 13 Company Profiles

  • ABBOTT
  • BD BIOSCIENCES
  • BECKMAN COULTER INC.
  • BIOMERIEUX
  • BIO-RAD (ABD SEROTEC)
  • BRISTOL-MYERS SQUIBB
  • EUROIMMUN (PERKINELMER)
  • F. HOFFMANN-LA ROCHE AG
  • SIEMENS HEALTHCARE
  • THERMO FISHER SCIENTIFIC INC.
  • TRINITY BIOTECH GROUP (IMMCO DIAGNOSTICS)

Chapter 14 Appendix: Acronyms

List of Tables

  • Summary Table : Global Market for Autoimmune Disease Diagnostics, by Indication, Through 2026
  • Table 1 : Association of Immune Dysfunction Syndromes Associate with Autoimmune Diseases
  • Table 2 : Infectious Etiologies of Selected Autoimmune Diseases
  • Table 3 : List of Autoimmune and Autoimmune Related Diseases
  • Table 4 : Autoantibodies and Associated Diseases
  • Table 5 : Challenges Faced by Immunoassay Kit/Instrument Manufacturers
  • Table 6 : Challenges Faced by Immunoassay Clinical Laboratories
  • Table 7 : Immunoassay Challenges Faced by Physicians
  • Table 8 : Global Market for Autoimmune Disease Diagnostics, by Gender, Through 2026
  • Table 9 : Global Market for Autoimmune Disease Diagnostics in Female, by Region, Through 2026
  • Table 10 : Global Market for Autoimmune Disease Diagnostics in Male, by Region, Through 2026
  • Table 11 : Global Market for Autoimmune Disease Diagnostics, by Technology, Through 2026
  • Table 12 : ANA Patterns and Associated Diseases
  • Table 13 : Conditions Associated with Positive IIF-ANA Results
  • Table 14 : Global Market for Indirect Immunofluorescence (IIF) of Autoimmune Disease Diagnostics, by Region, Through 2026
  • Table 15 : Global Market for Enzyme-linked Immunosorbent Assay (ELISA) of Autoimmune Disease Diagnostics, by Region, Through 2026
  • Table 16 : Global Market for ImmunoBlot of Autoimmune Disease Diagnostics, by Region, Through 2026
  • Table 17 : Global Market for Multiplex Immunoassays of Autoimmune Disease Diagnostics, by Region, Through 2026
  • Table 18 : Global Market for Other Technologies Segment of Autoimmune Disease Diagnostics, by Region, Through 2026
  • Table 19 : Prevalence of ANA in Various Connective Tissue Diseases (CTD)
  • Table 20 : Performance of Laboratory Methods in Detection of Autoimmune Antibodies
  • Table 21 : Autoimmune Products Sold, by Selected Multinational Companies, by Technology
  • Table 22 : Global Market for Autoimmune Disease Diagnostics, by Indication, Through 2026
  • Table 23 : Global Market for Autoimmune Disease Diagnostics for Type 1 Diabetes, by Region, Through 2026
  • Table 24 : Global Market for Autoimmune Disease Diagnostics for Rheumatoid Arthritis, by Region, Through 2026
  • Table 25 : Global Market for Autoimmune Disease Diagnostics for Psoriasis/Psoriatic Arthritis, by Region, Through 2026
  • Table 26 : Drugs in the Pipeline for Psoriatic Disease
  • Table 27 : Global Market for Autoimmune Disease Diagnostics for Multiple Sclerosis, by Region, Through 2026
  • Table 28 : Global Market for Autoimmune Disease Diagnostics for Inflammatory Bowel Disease, by Region, Through 2026
  • Table 29 : Global Market for Autoimmune Disease Diagnostics for Systemic Lupus Erythematosus, by Region, Through 2026
  • Table 30 : Global Market for Autoimmune Disease Diagnostics for Other Diseases Indication, by Region, Through 2026
  • Table 31 : Global Market for Autoimmune Disease Diagnostics, by Region, Through 2026
  • Table 32 : North American Market for Autoimmune Disease Diagnostics, by Gender, Through 2026
  • Table 33 : North American Market for Autoimmune Disease Diagnostics, by Technology, Through 2026
  • Table 34 : North American Market for Autoimmune Disease Diagnostics, by Indication, Through 2026
  • Table 35 : North American Market for Autoimmune Disease Diagnostics, by Country, Through 2026
  • Table 36 : European Market for Autoimmune Disease Diagnostics, by Gender, Through 2026
  • Table 37 : European Market for Autoimmune Disease Diagnostics, by Technology, Through 2026
  • Table 38 : European Market for Autoimmune Disease Diagnostics, by Indication, Through 2026
  • Table 39 : European Market for Autoimmune Disease Diagnostics, by Country, Through 2026
  • Table 40 : Asia-Pacific Market for Autoimmune Disease Diagnostics, by Gender, Through 2026
  • Table 41 : Asia-Pacific Market for Autoimmune Disease Diagnostics, by Technology, Through 2026
  • Table 42 : Asia-Pacific Market for Autoimmune Disease Diagnostics, by Indication, Through 2026
  • Table 43 : Asia-Pacific Market for Autoimmune Disease Diagnostics, by Country, Through 2026
  • Table 44 : Rest of World Market for Autoimmune Disease Diagnostics, by Gender, Through 2026
  • Table 45 : Rest of World Market for Autoimmune Disease Diagnostics, by Technology, Through 2026
  • Table 46 : Rest of World Market for Autoimmune Disease Diagnostics, by Indication, Through 2026
  • Table 47 : Rest of World Market for Autoimmune Disease Diagnostics, by Country, Through 2026
  • Table 48 : Pharmaceutical Companies Involved in COVID-19 Testing and Research
  • Table 49 : Companies Offering FDA Emergency Use Authorization Serology Tests with Locations in the United States
  • Table 50 : Per Capita Health Expenditure in Select Countries, 2016-2018
  • Table 51 : Out-of-Pocket Health Expenditures, by Major Countries, 2016-2018
  • Table 52 : Diagnostic Chains Well-positioned to Improve their Operating Parameters Within India
  • Table 53 : Major Manufacturers of Autoimmune Disease Diagnostics, by Revenue* and Number of Employees, 2020
  • Table 54 : Differences between U.S. and European Government Regulations for Medical Devices
  • Table 55 : Regulation of Medical Diagnostics in Selected Asia-Pacific Countries
  • Table 56 : Major Mergers and Acquisitions in the Global Autoimmune Disease Diagnostics Market, 2021
  • Table 57 : Agreements, Launches, Collaborations and Partnerships in the Global Autoimmune Disease Diagnostics Market, 2021
  • Table 58 : Abbott: Product Portfolio
  • Table 59 : BD Biosciences: Product Portfolio
  • Table 60 : Beckman Coulter Inc (Danaher).: Product Portfolio
  • Table 61 : bioMerieux: Product Portfolio
  • Table 62 : Bio-Rad: Product Portfolio
  • Table 63 : Bristol-Myers Squibb: Product Portfolio
  • Table 64 : Euroimmun (PerkinElmer): Product Portfolio
  • Table 65 : F. Hoffmann-La Roche AG: Product Portfolio
  • Table 66 : Siemens Healthcare: Product Portfolio
  • Table 67 : Thermo Fisher Scientific: Product Portfolio
  • Table 68 : Trinity Biotech: Product Portfolio
  • Table 69 : Acronyms Used in This Report

List of Figures

  • Summary Figure : Global Market Shares of Autoimmune Disease Diagnostics, by Indication, 2020
  • Figure 1 : Prevalence of Selected Autoimmune Diseases in the U.S., 2020
  • Figure 2 : Prevalence of Diagnosed Autoimmune Conditions in Selected Countries, 2019
  • Figure 3 : Deaths Due to Diabetes in Adults, by Age Group and Sex, 2019
  • Figure 4 : Number of Diabetes Patients (Ages 20-79 years), Projection and Trends, 2000-2045
  • Figure 5 : Technological Development for Some Autoimmune Diseases
  • Figure 6 : Global Market Shares of Autoimmune Disease Diagnostics, by Gender, 2020
  • Figure 7 : Global Market for Autoimmune Disease Diagnostics in Female, 2019-2026
  • Figure 8 : Global Market for Autoimmune Disease Diagnostics in Female, by Region, 2019-2026
  • Figure 9 : Global Market for Autoimmune Disease Diagnostics in Male, 2019-2026
  • Figure 10 : Global Market for Autoimmune Disease Diagnostics in Male, by Region, 2019-2026
  • Figure 11 : Global Market Shares of Autoimmune Disease Diagnostics, by Technology, 2020
  • Figure 12 : IIF-ANA Test Methodology
  • Figure 13 : Global Market for Indirect Immunofluorescence (IIF) of Autoimmune Disease Diagnostics, 2019-2026
  • Figure 14 : Global Market for IIF of Autoimmune Disease Diagnostics, by Region, 2019-2026
  • Figure 15 : ELISA Testing Methodology
  • Figure 16 : Global Market for Enzyme-linked Immunosorbent Assay (ELISA) of Autoimmune Disease Diagnostics, 2019-2026
  • Figure 17 : Global Market for ELISA of Autoimmune Disease Diagnostics, by Region, 2019-2026
  • Figure 18 : Western Blot Methodology
  • Figure 19 : Dot Blot Test Assay Methodology
  • Figure 20 : ANA Line Assay Methodology
  • Figure 21 : Global Market for ImmunoBlot Test Assay of Autoimmune Disease Diagnostics, 2019-2026
  • Figure 22 : Global Market for ImmunoBlot of Autoimmune Disease Diagnostics, by Region, 2019-2026
  • Figure 23 : ANA Flow Cytometry Assay Methodology
  • Figure 24 : Global Market for Multiplex Immunoassays of Autoimmune Disease Diagnostics, 2019-2026
  • Figure 25 : Global Market for Multiplex Immunoassays of Autoimmune Disease Diagnostics, by Region, 2019-2026
  • Figure 26 : ANA Agglutination Assay Methodology
  • Figure 27 : ANA Double Immune Diffusion Assay Methodology
  • Figure 28 : Counterimmunoelectrophoresis Methodology
  • Figure 29 : Global Market for Other Technologies Segment of Autoimmune Disease Diagnostics, 2019-2026
  • Figure 30 : Global Market for Other Technologies Segment of Autoimmune Disease Diagnostics, by Region, 2019-2026
  • Figure 31 : Global Market Shares of Autoimmune Disease Diagnostics, by Indication, 2020
  • Figure 32 : Global Prevalence of Major Autoimmune Diseases, 2016 and 2017
  • Figure 33 : Global Market for Autoimmune Disease Diagnostics for Type 1 Diabetes, 2019-2026
  • Figure 34 : Global Market for Autoimmune Disease Diagnostics for Type 1 Diabetes, by Region, 2019-2026
  • Figure 35 : Global Market for Autoimmune Disease Diagnostics for Rheumatoid Arthritis, 2019-2026
  • Figure 36 : Global Market for Autoimmune Disease Diagnostics for Rheumatoid Arthritis, by Region, 2019-2026
  • Figure 37 : Global Market for Autoimmune Disease Diagnostics for Psoriasis/Psoriatic Arthritis, 2019-2026
  • Figure 38 : Global Market for Autoimmune Disease Diagnostics for Psoriasis/Psoriatic Arthritis, by Region, 2019-2026
  • Figure 39 : Global Market for Autoimmune Disease Diagnostics for Multiple Sclerosis, 2019-2026
  • Figure 40 : Global Market for Autoimmune Disease Diagnostics for Multiple Sclerosis, by Region, 2019-2026
  • Figure 41 : Global Market for Autoimmune Disease Diagnostics for Inflammatory Bowel Disease, 2019-2026
  • Figure 42 : Global Market for Autoimmune Disease Diagnostics for Inflammatory Bowel Disease, by Region, 2019-2026
  • Figure 43 : Global Market for Autoimmune Disease Diagnostics for Systemic Lupus Erythematosus, 2019-2026
  • Figure 44 : Global Market for Autoimmune Disease Diagnostics for Systemic Lupus Erythematosus, by Region, 2019-2026
  • Figure 45 : Global Market for Autoimmune Disease Diagnostics for Other Diseases Indication, 2019-2026
  • Figure 46 : Global Market for Autoimmune Disease Diagnostics for Other Diseases Indication, by Region, 2019-2026
  • Figure 47 : Global Market Shares of Autoimmune Disease Diagnostics, by Region, 2020
  • Figure 48 : North American Market Shares of Autoimmune Disease Diagnostics, by Gender, 2020
  • Figure 49 : North American Market Shares of Autoimmune Disease Diagnostics, by Technology, 2020
  • Figure 50 : North American Market Shares of Autoimmune Disease Diagnostics, by Indication, 2020
  • Figure 51 : North American Market Shares of Autoimmune Disease Diagnostics, by Country, 2020
  • Figure 52 : U.S. Market for Autoimmune Disease Diagnostics, 2019-2026
  • Figure 53 : Canadian Market for Autoimmune Disease Diagnostics, 2019-2026
  • Figure 54 : Mexican Market for Autoimmune Disease Diagnostics, 2019-2026
  • Figure 55 : European Market Shares of Autoimmune Disease Diagnostics, by Gender, 2020
  • Figure 56 : European Market Shares of Autoimmune Disease Diagnostics, by Technology, 2020
  • Figure 57 : European Market Shares of Autoimmune Disease Diagnostics, by Indication, 2020
  • Figure 58 : European Market Shares of Autoimmune Disease Diagnostics, by Country, 2020
  • Figure 59 : German Market for Autoimmune Disease Diagnostics, 2019-2026
  • Figure 60 : French Market for Autoimmune Disease Diagnostics, 2019-2026
  • Figure 61 : U.K. Market for Autoimmune Disease Diagnostics, 2019-2026
  • Figure 62 : Italian Market for Autoimmune Disease Diagnostics, 2019-2026
  • Figure 63 : Spanish Market for Autoimmune Disease Diagnostics, 2019-2026
  • Figure 64 : Rest of the European Market for Autoimmune Disease Diagnostics, 2019-2026
  • Figure 65 : Asia-Pacific Market Shares of Autoimmune Disease Diagnostics, by Gender, 2020
  • Figure 66 : Asia-Pacific Market Shares of Autoimmune Disease Diagnostics, by Technology, 2020
  • Figure 67 : Asia-Pacific Market Shares of Autoimmune Disease Diagnostics, by Indication, 2020
  • Figure 68 : Asia-Pacific Market Shares of Autoimmune Disease Diagnostics, by Country, 2020
  • Figure 69 : Japanese Market for Autoimmune Disease Diagnostics, 2019-2026
  • Figure 70 : Chinese Market for Autoimmune Disease Diagnostics, 2019-2026
  • Figure 71 : Share of Autoimmune Disease Diagnostic Costs* in China, by Type of Therapy, 2020
  • Figure 72 : Indian Market for Autoimmune Disease Diagnostics, 2019-2026
  • Figure 73 : Australian and New Zealand Market for Autoimmune Disease Diagnostics, 2019-2026
  • Figure 74 : Healthcare Expenditure in Australia, 2015 and 2016
  • Figure 75 : Rest of Asia-Pacific Market for Autoimmune Disease Diagnostics, 2019-2026
  • Figure 76 : Rest of World Market Shares of Autoimmune Disease Diagnostics, by Gender, 2020
  • Figure 77 : Rest of World Market Shares of Autoimmune Disease Diagnostics, by Technology, 2020
  • Figure 78 : Rest of World Market Shares of Autoimmune Disease Diagnostics, by Indication, 2020
  • Figure 79 : Rest of World Market Shares of Autoimmune Disease Diagnostics, by Country, 2020
  • Figure 80 : Brazilian Market for Autoimmune Disease Diagnostics, 2019-2026
  • Figure 81 : GCC Countries Market for Autoimmune Disease Diagnostics, 2019-2026
  • Figure 82 : South African Market for Autoimmune Disease Diagnostics, 2019-2026
  • Figure 83 : Other RoW Countries Market for Autoimmune Disease Diagnostics, 2019-2026
  • Figure 84 : Ups and Down of Diagnostic Field during COVID-19
  • Figure 85 : Autoimmune Disease Diagnostics Industry Value Chain
  • Figure 86 : Per Capita Health Expenditure in Select Countries, 2016-2018
  • Figure 87 : Molecular Tests Approved in the United States, by Therapy Area, 2016
  • Figure 88 : Global Market Shares of Autoimmune Disease Diagnostics, by Manufacturer, 2020
  • Figure 89 : SWOT Analysis of the Global Autoimmune Disease Diagnostics Market
  • Figure 90 : Abbott: Annual Revenue, 2016-2020
  • Figure 91 : Abbott: Revenue Share, by Country, 2020
  • Figure 92 : Abbott: Revenue Share, by Business Unit, 2020
  • Figure 93 : BD Biosciences: Annual Revenue, 2017-2020
  • Figure 94 : BD Biosciences: Revenue Share, by Business Segment, 2020
  • Figure 95 : BD Biosciences: Revenue Share, by Medical Segment, 2020
  • Figure 96 : Beckman Coulter Inc (Danaher): Annual Revenue, 2018-2020
  • Figure 97 : Beckman Coulter Inc (Danaher): Revenue Share, by Region in Diagnostic Segment, 2020
  • Figure 98 : Beckman Coulter Inc (Danaher): Revenue Share, by Business Segment, 2020
  • Figure 99 : bioMerieux: Annual Revenue, 2018-2020
  • Figure 100 : bioMerieux: Revenue Share, by Region/Country, 2020
  • Figure 101 : bioMerieux: Revenue Share, by Business Unit, 2019
  • Figure 102 : Bio-Rad: Annual Revenue, 2017-2020
  • Figure 103 : Bio-Rad: Revenue Share, by Region, 2020
  • Figure 104 : Bio-Rad: Revenue Share, by Business Unit, 2020
  • Figure 105 : Bristol-Myers Squibb: Annual Revenue, 2016-2020
  • Figure 106 : Bristol-Myers Squibb: Revenue Share, by Region, 2020
  • Figure 107 : Bristol-Myers Squibb: R&D Market Share, 2019 and 2020
  • Figure 108 : Euroimmun (PerkinElmer): Annual Revenue, 2017-2020
  • Figure 109 : Euroimmun (PerkinElmer): Revenue Share, by Region, 2020
  • Figure 110 : Euroimmun (PerkinElmer): Revenue Share, by Business Unit, 2019
  • Figure 111 : F. Hoffmann-La Roche AG: Annual Revenue, 2016-2020
  • Figure 112 : F. Hoffmann-La Roche AG: Revenue Share in Diagnostic Segment, by Region, 2020
  • Figure 113 : F. Hoffmann-La Roche AG: Revenue Share, by Diagnostic Segment, 2019
  • Figure 114 : Siemens Healthcare: Annual Revenue, 2019 and 2020
  • Figure 115 : Siemens Healthcare: Revenue Share, by Region, 2020
  • Figure 116 : Siemens Healthcare: Revenue Share, by Business Unit, 2020
  • Figure 117 : Thermo Fisher Scientific: Annual Revenue, 2016-2020
  • Figure 118 : Thermo Fisher Scientific: Revenue Share, by Region, 2020
  • Figure 119 : Thermo Fisher Scientific: Revenue Share, by Business Segment, 2020
  • Figure 120 : Trinity Biotech: Annual Revenue, 2019 and 2020
  • Figure 121 : Trinity Biotech: Revenue Share, by Region, 2020
  • Figure 122 : Trinity Biotech: Revenue Share, by Business Segment, 2020